← Open Payments lookup

JAMES HENDERSON: Open Payments

NPI 1780244608 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$770 in 40 payments from 11 companies in 2025. Trend: 2023 $1,060 · 2024 $1,470 · 2025 $770

Food & beverage: $770
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$230
ABBVIE INC.11$184
Vanda Pharmaceuticals Inc.5$102
Supernus Pharmaceuticals, Inc.3$61
Otsuka America Pharmaceutical, Inc.2$52
Axsome Therapeutics, Inc.2$37
Janssen Pharmaceuticals, Inc2$33
Corium, LLC1$22
Collegium Pharmaceutical, Inc.1$18
Otsuka Pharmaceutical Development & Commercialization, Inc.1$17

Products named: CAPLYTA, VRAYLAR, FANAPT, REXULTI, Qelbree, Auvelity, SPRAVATO, Azstarys.

Industry payments across AL — which companies pay providers there.